Published in Bone Marrow Transplant on October 12, 2015
Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med (2012) 10.93
Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45
Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant (2007) 4.99
Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation (2007) 3.69
Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med (2010) 2.92
Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol (2011) 2.89
Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA (2004) 2.65
Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol (2009) 2.62
Quality of life after allogeneic hematopoietic cell transplantation. Blood (2009) 2.49
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol (2011) 2.31
Reporting and grading financial toxicity. J Clin Oncol (2014) 2.31
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology (2009) 1.98
Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int (2005) 1.85
Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J Clin Oncol (2013) 1.66
Validation of the PTSD Checklist-Civilian Version in survivors of bone marrow transplantation. J Trauma Stress (1999) 1.47
Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. The Renal Physicians Association and the American Society of Nephrology. J Am Soc Nephrol (2000) 1.44
Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia (2004) 1.37
Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer (2013) 1.36
Construct validity of the posttraumatic stress disorder checklist in cancer survivors: analyses based on two samples. Psychol Assess (2004) 1.35
Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology (2003) 1.32
Prevalence of hematopoietic cell transplant survivors in the United States. Biol Blood Marrow Transplant (2013) 1.30
Importance of a comprehensive geriatric assessment in prediction of complications following thoracic surgery in elderly patients. Chest (2005) 1.26
Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transplant (2005) 1.26
Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. J Clin Oncol (2011) 1.24
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica (2012) 1.24
Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol (2010) 1.21
The development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer (2014) 1.21
Financial burden in recipients of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2014) 1.19
Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood (2004) 1.19
Impairment in functional status and survival in patients with acute myeloid leukaemia. J Cancer Res Clin Oncol (2006) 1.16
Psychological distress in long-term survivors of hematopoietic stem cell transplantation. Psychooncology (2008) 1.11
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica (2014) 1.07
Underutilization of peritoneal dialysis. JAMA (2004) 1.05
Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia. Blood (2013) 1.04
Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplant (2005) 1.04
To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century. Bone Marrow Transplant (2013) 1.01
Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer (2002) 1.01
Prognostic factor and quality of life analysis in 160 patients aged > or =60 years with hematologic neoplasias treated with allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2010) 1.01
Older cancer patients' information and support needs surrounding treatment: An evaluation through the eyes of patients, relatives and professionals. BMC Nurs (2009) 0.97
Changes in cognitive functioning in the year after hematopoietic stem cell transplantation. Cancer (2007) 0.97
How I treat older patients with ALL. Blood (2013) 0.97
Acute myeloid leukemia and myelodysplastic syndromes in older adults. J Clin Oncol (2014) 0.97
The geriatric assessment. Am Fam Physician (2011) 0.96
Patient education in allogeneic hematopoietic cell transplant: what patients wish they had known about quality of life. Bone Marrow Transplant (2013) 0.93
The experience of leukaemia and bone marrow transplant: searching for meaning and agency. Psychooncology (2003) 0.92
The basis of informed consent for BMT patients. Bone Marrow Transplant (1999) 0.90
Need for change in patient education: a Finnish survey from the patient's perspective. Patient Educ Couns (2003) 0.89
Expectations and received knowledge by surgical patients. Int J Qual Health Care (2007) 0.88
Social support and survival in patients with acute myeloid leukaemia. Support Care Cancer (2006) 0.87
Emerging diagnostic and therapeutic approaches in core binding factor acute myeloid leukaemia. Curr Opin Hematol (2015) 0.85
Knowledge expectations of patients on dialysis treatment. Nephrol Nurs J (2008) 0.84
Implementing and evaluating shared decision making in oncology practice. CA Cancer J Clin (2014) 0.84
Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2014) 0.82
Is 'informed consent' an 'understood consent' in hematopoietic cell transplantation? Bone Marrow Transplant (2014) 0.80
Discussing cancer prognosis. Oncology (Williston Park) (2015) 0.78
Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients. Philos Ethics Humanit Med (2014) 0.77
Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation. Bone Marrow Transplant (2014) 0.88
Pregnancy After Kidney Transplantation: Outcomes, Tacrolimus Doses, and Trough Levels. Transplant Proc (2015) 0.81
Kidney transplantation in immunologically high-risk patients. Transplant Proc (2013) 0.78
Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. Transplant Proc (2004) 0.77
Is There a Long-Term Risk for Donors With Heterozygous MEFV Mutation After Kidney Donation? Transplant Proc (2017) 0.75
Average Tacrolimus Trough Level in the First Month After Transplantation May Predict Acute Rejection. Transplant Proc (2017) 0.75